Skip to main content
TrendingNews.today
World News
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
As of Apr 2
TechUnited States1 sourcesNeutral

Biotech IPOs Rebound as AI Takes a More Central Role in Drug Development

The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force behind this resurgence.

TM
tristan manalac
via Biospace
ShareRead original

Read the full article at Biospace →

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Biospace
Biospace
NewsDataUS

Comments

0 comments
Be respectful and constructive.
Loading comments...
Previous
Gyokeres to the rescue as Sweden beat Poland in thriller to reach World Cup
Next
ORNL to Feature Transformative Tech at ARPA-E Summit

Related Articles

IBM Partners With Arm To Develop Dual-architecture Hardware For AI Enterprise WorkloadsTech
IBM Partners With Arm To Develop Dual-architecture Hardware For AI Enterprise Workloads
Unknown-7h ago-1 sources
Tips to help identify AI-generated false newsTech
Tips to help identify AI-generated false news
Barbara Whitaker,Melissa Goldin-8h ago-1 sources
Trump says US has plenty of jet fuel for Europe, market disagreesTech
Trump says US has plenty of jet fuel for Europe, market disagrees
Reuters-12h ago-1 sources